Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision v3.6.3 has been added and v3.6.2 removed, indicating a minor update to the page version of the study record rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.2 added to the page. This signals an internal update to the page version/template rather than a content change.
    Difference
    0.1%
    Check dated 2026-06-26T19:52:18.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a banner states recruitment is closed with 'No longer looking for participants.' The revision/version label was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:24:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The site now displays a new Revision tag v3.5.5, replacing the previous Revision tag v3.5.4. This indicates a minor version update in the site's revision history rather than a change to study content or public-facing functionality.
    Difference
    0.1%
    Check dated 2026-06-05T08:20:15.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The study record now shows results have been posted and the design uses parallel assignment (replacing the prior single-group setup), along with updated results dates and related documents (Informed Consent Form and Study Protocol/SAP).
    Difference
    2%
    Check dated 2026-05-14T22:55:50.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The site revision was updated to v3.5.3, replacing the previous v3.5.2. This reflects a metadata/version update rather than changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T15:42:26.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.